Skip to main content
SpringerLink
Log in

Maligne Systemerkrankungen

  • Chapter
Strahlentherapie

Zusammenfassung

Unter dem Begriff der malignen Systemerkrankungen verstehen wir die Neoplasien des lymphoreticulären und myeloischen Gewebes. Besonders in den letzten 10 Jahren wurden die Bemühungen intensiviert, Fragen der Ätiologie, Epidemiologie, histopathologi-schen Klassifikation und klinischen Stadieneinteilung dieser Erkrankungen zu klären, um die Voraussetzungen für verbesserte Behandlungsverfahren, insbesondere auch den adäquaten Einsatz der Strahlentherapie, zu schaffen. Bei den malignen Lymphomen leisteten Arbeiten über die Hodgkinsche Erkrankung Schrittmacherdienste. Sie sind beispielhaft für interdisziplinäres und internationales Teamwork, dokumentiert in einer Reihe von Symposien und Konferenzen, die 1965 in Paris (1966) und Rye/New York (1966), in Ann Arbor (1971), 1972 in Stanford (1973), 1973 in London (1975) und 1976 in San Francisco (1977) abgehalten wurden. Als Ergebnis verfügen wir heute bei der Hodgkinschen Erkrankung über klare Konzepte der histologischen und klinischen Klassifikation und damit über Richtlinien für eine bestmögliche Therapie. Der Fortschritt dokumentiert sich in einer signifikanten Verbesserung der Lebenserwartung und in einem hohen Prozentsatz von Heilungen dieser bis dahin unheilbaren Erkrankung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abbatucci JS, van der Werf-Messing B (1975) EORTC Radio-Chemotherapy Cooperative Group. Clinical trial using radiotherapy and chemotherapy in Non-Hodgkin-Lymphoma. Chairman: Abbatucci JS. Study Secretary: van der Werf-Messing B. Protocol 20751, June 1975

    Google Scholar 

  • Aigner K, Dobroschke J, Schwemmle K (1978) Splenektomie bei malignen Lymphomen aus chirurgischer Sicht. Klinikarzt 7: 888–893

    Google Scholar 

  • Airlie House Warrenton, Virginia (1975) Invitational workshop for the planning of retrospective and prospective studies to delineate optimal classfications of the Non-Hodg-kin’s lymphomas. September 4–5 (1975)

    Google Scholar 

  • Andersen V, Weeke E, Killmann SA (1974) Extracorporal irradiation of the blood: clinical applications, Strahlentherapie 148: 603–613

    PubMed  CAS  Google Scholar 

  • Arndt J (1973) Indikationen und Grenzen der Strahlentherapie bösartiger Neubildungen. Fischer, Stuttgart

    Google Scholar 

  • Arseneau JC, Canellos GP, Johnson RJ, DeVita VT (1977) Risk of new cancers in patients with Hodgkin’s disease. Cancer 40: 1912–1916

    PubMed  CAS  Google Scholar 

  • Banfi A, Bonadonna G, Carnevali G, Oldini C, Salvini E (1968) Preferential sites of involvement and spread in malignant lymphomas. Europ J Cancer 4: 319–324

    CAS  Google Scholar 

  • Bauer R (1959) Die Strahlenbehandlung der Hämoblastosen. Strahlenforschung und Krebsbehandlung. Strahlentherapie Sonderbd 43: 223–236

    Google Scholar 

  • Begemann H, Harwerth H-G (1967) Praktische Hämatologie, 3. Aufl. Thieme, Stuttgart, S 134–139

    Google Scholar 

  • Begemann H, Theml H (1978) Zur Frage der Splenektomie bei der Lymphogranulomatose (Morbus Hodgkin) — Pathophysiologische und klinische Gesichtspunkte. Klinikarzt 7: 714–724

    Google Scholar 

  • Begemann H, Rastetter J, Kaboth W (1970) Klinische Hämatologie. Thieme, Stuttgart

    Google Scholar 

  • Bennett MH (1975) Sclerosis in Hon-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 44–52

    Google Scholar 

  • Bennett MH, Millet YL (1969) Nodular sclerotic lymphosarcoma, a possible new clinico-pathological entity. Clin Radiol 20: 339

    PubMed  CAS  Google Scholar 

  • Bitran JD, Kinzie J, Sweet DL, Variakojis D, Griem ML, Golomb HM, Miller JB, Noetzel N, Ultmann JE (1977) Survival of patients with localized histiocytic lymphoma. Cancer 39: 342–346

    PubMed  CAS  Google Scholar 

  • Bonadonna G, Uslenghi C, Zucali R (1975) Recent trends in the medical treatment of Hodgkin’s disease. Europ J Cancer 11: 251–266

    CAS  Google Scholar 

  • Bopp JH, Günther D (1970) Die Strahlenbehandlung des eosinophilen Granuloms. Strahlentherapie 140: 143–147

    PubMed  CAS  Google Scholar 

  • Bousser J, Bilski-Pasquier G, Blane C (1967) Vergleichende Untersuchungen zur Behandlung der chronischen myeloischen Leukämie mit Röntgenstrahlen und Myleran. Deutscher Röntgenkongreß 1966. Sonderband zur Strahlentherapie, Teil B: 271–275

    Google Scholar 

  • Brittinger G, Bartels H, Bremer K, Dühmke E, Gunzer U, König E, Stein H (1976) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphobla-stisches Lymphom, immunoblastisches Lymphom. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd 18. Lehmann, München, S 211–223

    Google Scholar 

  • Brittinger G, Bartels H, Bremer K, Burger A, Dühmke E, Gunzer U, König F, Schmalhorst U, Stacher A, Stein H, Theml H, Waldener R (Kieler Lymphomgruppe) (1978) Klinische Bedeutung der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. In: Hartwich G (Hrsg) Diagnose und Therapie von Leukämien und malignen Lymphomen. Straube, Erlangen, S 57–66

    Google Scholar 

  • Brittinger G, Bartels H, Burger A, Dühmke E, Fülle HH, Gunzer U, Heinz R, Huhn D, Löhr GW, Musshoff K, Nowicki L, Pfoch M, Pralle H, Schmalhorst U (Kieler Lymphomgruppe (1979) Grundlagen und bisherige Ergebnisse der prospektiven Studie der Kieler Lymphomgruppe über Non-Hodgkin-Lymphom. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwarzenberg, München Wien Baltimore, S 193–200

    Google Scholar 

  • Brown TC, Peters MV, Bergsagel DE, Reid J (1975) A retrospective analysis of the clinical results in relation to the Rappaport histological classification. Symposium on Non-Hodgkin’s lymphomata. London, October 8–12, 1973. Brit J Cancer 31, Suppl II: 174–186

    Google Scholar 

  • Brunner H (1942) Nasopharyngeal fibroma. Ann Otol Rhinol Laryngol 51: 29–65

    Google Scholar 

  • Bruntsch U, Beersik F, Eigler FW, Grub R, van Lessen H, Löhr GW, Musshoff K, Schmidt CG, Slanina J (1977) Primäre und sekundäre explorative Laparatomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 102:1799–1804

    PubMed  CAS  Google Scholar 

  • Butler JJ (1971) Relationship of histological findings to survival in Hodgkin’s disease. Cancer Res 31: 1170–1775

    Google Scholar 

  • Cadman EC, Capizzi RL, Bertino JR (1977) Acute nonlymphocytic leukemia. A delayed complication of Hodgkin’s disease therapy: analysis of 109 cases. Cancer 40: 1280–1296

    PubMed  CAS  Google Scholar 

  • Canellos GP, Young RC, DeVita VT (1972) Combination chemotherapy for advanced Hodgkin’s disease in relaps following extensive radiotherapy. Clin Pharmacol Ther 13: 750–754

    Google Scholar 

  • Candios GP, De Vita VT, Young RC, Chabner BA, Schein PS, Johnson RE (1975a) Therapy of advanced lymphocytic lymphoma; a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. Brit J Cancer 31, Suppl II: 474–480

    Google Scholar 

  • Canellos G, De Vita VT, Arseneau JC, Whang-Peng J, Johnson REC (1975b) Second malignancies complicating Hodgkin’s disease in remission. Lancet 2: 947–949

    Google Scholar 

  • Carbone P-P (1972) Non-Hodgkin’s lymphoma: recent observations on natural history and intensive treatment. Cancer (Philadelphia) 30: 1511–1515

    CAS  Google Scholar 

  • Carbone PP, Kaplan HS, Musshoff K, Smithers IW, Tubiana M (1971) Report of the Hodgkin’s disease staging classification committee. Conference on staging in Hodgkin’s disease. Ann Arbor, April 26–28, 1971. Cancer Res 31: 1860–1861

    PubMed  CAS  Google Scholar 

  • Carbone PP, Spurr C (1968) Management of patients with malignant lymphoma. A comparative study with cyclophosphamide and vinca alcaloids. Cancer Res 28: 811–822

    PubMed  CAS  Google Scholar 

  • Chaffey JT, Rosenthal DS, Pinkus G, Helmann S (1975) Advanced lymphosarcoma treated by total body irradiation. Brit J Cancer 31, Suppl II: 441–449

    Google Scholar 

  • Cheyne C (1971) Histiocytosis X. J. Bone Jt Surg 53 B: 366–382

    Google Scholar 

  • Chilcote RR, Baehner RL, Hammond D (1976) Septicemia and meningitis in children splenectomized for Hodgkin’s disease. Engl J Med 295: 798–800

    CAS  Google Scholar 

  • Conference on Non-Hodgkin’s lymphomas (San Francisco, Sept. 30-Oct. 2, 1976) Proceedings of the (1977) Jones StE, Godden J (eds). Cancer Treat Rep 935–1227

    Google Scholar 

  • Conklin R, Alexanian R (1975) Clinical classification of plasma cell myeloma. Arch Int Med 135: 139–143

    CAS  Google Scholar 

  • Cox JD (1978) Central lymphatic irradiation to low dose advanced nodular lympho-reticular tumors (Non-Hodgkin’s lymphoma). Radiology 126: 767–772

    PubMed  CAS  Google Scholar 

  • Cox JD, Koehl RH, Turner WM, King FM (1974) Irradiation in the local control of malignant lymphoreticular tumors (Non-Hodgkin’s malignant lymphoma). Radiology 112: 179–185

    PubMed  CAS  Google Scholar 

  • Craft CB (1940) Results with roentgen ray therapy in Hodgkin’s disease. Bull Staff Meet Univ Minn Hosp 11: 391–409

    Google Scholar 

  • Cronkite EP, Chanana AD, Schnappauf H (1965) Extracorporal irradiation of blood and lymph in animals: its effect on homografts and on lymphoma. New Engl J Med 272: 456–461

    PubMed  CAS  Google Scholar 

  • Cronkite EP, Jansen CR, Cottier H, Rai K, Sipe CR (1964) Lymphocytic production measured by extracorporal irradiation, cannulation and labeling techniques. Ann NY Acad Sci 113:566–577

    PubMed  CAS  Google Scholar 

  • Dancot H (1967) Über die Heilungsaussichten bei Lymphosarkomen und Retikulosarkomen durch Bestrahlung (Ergebnisse einer Untersuchung bei 395 Fällen). Deutscher Röntgenkongreß 1966, Teil B, Strahlenbehandlung und Strahlenbiologie. Sonderbände zur Strahlentherapie 64: 283

    Google Scholar 

  • Dancot H, Feremans W (1974) The curability of lympho- and reticulosarcomas. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 201–205

    Google Scholar 

  • D’Angio GJ, Evans AE, Mitus A (1959) Roentgentherapy of certain complications of acute leukemia in childhood. Amer J Roentgenol 82: 541–553

    PubMed  Google Scholar 

  • Deelmann HT (1956) 1943–1954, zitiert nach Sluiter JFT: De histologie van de ziekte van Brill in haar verschillende phasen. Diss Med Amsterdam

    Google Scholar 

  • Del Regato JA (1941) Roentgentherapy of lymphosarcomas of the tonsil. Radiation Therapy Tumor Inst Seattle (No 2): 67–76

    Google Scholar 

  • Desser RK, Golomb HM, Ultmann JE, Ferguson DJ, Moran EM, Griem ML, Vardiman J, Kinzie JJ, Blough R (1977) Prognostic classification of Hodgkin’s disease in pathologic stage III based on anatomic considerations. Blood 49: 883–893

    PubMed  CAS  Google Scholar 

  • De Vita VT, Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Int Med 73: 881–895

    Google Scholar 

  • Djaldetti M, Devries A, Levi B, Patah T (1962) Haemolytic anaemia in lymphocytic leucaemia. Arch Intern Med 110: 449–455

    PubMed  CAS  Google Scholar 

  • Dorfman RF (1971) Relationship of histology to site in Hodgkin’s disease. Cancer Res 31: 1786–1793

    PubMed  CAS  Google Scholar 

  • Ellermann U, Bang O (1908) Experimentelle Leukämie bei Hühnern. Zbl Bakt 46:595–609

    Google Scholar 

  • Epstein MA, zur Hausen H, Bull G, Rabin H (1975) Pilot experiments with EB virus in owl monkeys. Int J Cancer 15: 17–22

    PubMed  CAS  Google Scholar 

  • Falk LA, Wolfe LG, Deinhardt F (1971) Oncogenesis of Herpesvirus saimiri in marmosets. Fed Proc 30: 514

    Google Scholar 

  • Farber S (1941) The nature of “solitary or eosinophilic granuloma” of bone. Amer J Path 17: 625–629

    Google Scholar 

  • Farhangi M, Osserman EF (1973) The treatment of multiple myeloma. Sem Hematol 10: 149–161

    CAS  Google Scholar 

  • Finkelstein JZ, Dyment PG, Hammond GD (1969) Leukemic infiltration of the testes during bone marrow remission. Pediatrics 43: 1042–1045

    Google Scholar 

  • Fransilla KO, Kalima TV, Voutilainen A (1967) Histological classification of Hodgkin’s disease. Cancer (Philadelphia) 20: 1594–1601

    Google Scholar 

  • Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer (Philadelphia) 29: 252–260

    CAS  Google Scholar 

  • Fuks Z, Bagshaw MA (1971) Total skin electron treatment of mycosis fungoides. Radiology 100: 145–150

    PubMed  CAS  Google Scholar 

  • Fuks Z, Bagshaw MA, Farber ME (1973) Prognostic signs and the management of the mycosis fungoides. Cancer (Philadelphia) 32: 1385–1395

    CAS  Google Scholar 

  • Fuller LM, Gamble JF, Butler JJ (1971) Influence of specific histology and clinical presentation on prognosis in localized Hodgkin’s disease treated with intensive large volume radiotherapy. J Radiol 98: 641–654

    CAS  Google Scholar 

  • Galbraith PR (1967) The mechanism of an action of splenic irradiation in chronic myelogenous leukemia. Canad Med Ass J 96: 1636–1641

    PubMed  CAS  Google Scholar 

  • Gall EA, Mallory TB (1942) Malignant lymphoma: A clinical-pathological survey of 618 cases. Amer J Path 18: 381–429

    PubMed  CAS  Google Scholar 

  • Gall EA, Rappaport M (1958) Seminar on diseases of lymph nodes and spleen. In: McDonald JE (ed) Proceedings of 23rd seminar, American Society of Clinical Pathology

    Google Scholar 

  • Galton DAG (1964) Chronic lymphocytic leukaemia: Its pathogenesis and relationship to lymphosarcoma. In: Roulet FC (ed) Symposium on lymphoreticular tumours in Africa, Paris 1963. Karger, Basel New York, pp 163–172

    Google Scholar 

  • Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnik JAM (1974) Classification on Non-Hodgkin’s lymphomas. Lancet 1974 II: 405–408

    Google Scholar 

  • Gilbert HA, Kagan AR (1978) Modern radiation oncology, Cap IV, Lymphomas. Harper & Row, Hagerstown New York San Fracisco London, pp 397–454

    Google Scholar 

  • Gilbert R (1939) Radiotherapy in Hodgkin’s disease (malignant granulomatosis): Anatomic and clinical foundations; governing principles; results. Amer J Roentgenol 41: 198–241

    Google Scholar 

  • Gilbert R, Babaiantz L (1931) Notre méthode de roentgenthérapie de la lymphogranu-lomatose (Hodgkin); résultats éloignés. Acta Radiol (Stockholm) 12: 523–529

    Google Scholar 

  • Glatstein E, Guernsey IM, Rosenberg SA, Kaplan HS (1969) The value of laparotomy and splenectomy in the staging of Hodgkin’s disease. Cancer 24: 709–718

    PubMed  CAS  Google Scholar 

  • Glatstein E, Kim H, Donaldson SS, Dorfman RF, Gribble TJ, Wilbur JR, Rosenberg SA, Kaplan HS (1974) Non-Hodgkin’s lymphomas. VI. Results of treatment in childhood. Cancer (Philadelphia) 34: 204

    CAS  Google Scholar 

  • Glatstein E, Fuchs E, Goffinet DR, Kaplan HS (1976) Non-Hodgkin’s lymphoma of stage III extent. Is total lymphoid irradiation appropriate treatment? Cancer 37: 2806–2812

    PubMed  CAS  Google Scholar 

  • Glatstein E, Portlock C, Rosenberg SA, Kaplan HS (1977) Combined modality treatment in the malignant lymphomas. Salmon SE, Jones SE (eds). Elsevier/North Holland, Amsterdam, pp 545–548

    Google Scholar 

  • Glick JH (1978) The treatment of stage III A Hodgkin’s disease: what is the role of combined modality therapy? Int J Radiat Oncol Biol Phys 4: 900–911

    Google Scholar 

  • Goffinet DR, Castellino RA, Kim H, Dorfman RF, Fuks Z, Rosenberg SA, Nelson T, Kaplan HS (1973) Staging laparatomy in unselected previously untreated patients with Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 32: 672–691

    CAS  Google Scholar 

  • Goffinet DR, Glatstein E, Fuks Z, Kaplan HS (1976) Abdominal irradiation in Non-Hodgkin’s lymphomas. Cancer 37: 2797–2806

    PubMed  CAS  Google Scholar 

  • Gough J (1970) Hodgkin’s disease; a correlation of histopathology with survival. Int J Cancer 5: 273–281

    PubMed  CAS  Google Scholar 

  • Hamann W, Oehlert W, Musshoff K, Nuß A, Schnellbacher B (1970) Histologic classification of Hodgkin’s disease and its relevance to prognosis. Germ Med Monthly 15: 509–514

    Google Scholar 

  • Han T, Stutzmann K (1967) Mode of spread in patients with localized malignant lym-phome. Arch Intern Med 120: 1–7

    PubMed  CAS  Google Scholar 

  • Hanks GE, Terry LN, Bryan JA, Newsome JF (1972) Contribution of diagnostic laparatomy to staging Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 29: 41–43

    CAS  Google Scholar 

  • Hausen zur H, Schulte-Holthausen H (1972) Detection of Epstein-Barr viral genomes in human tumor cells by nucleic acid hybridization. In: Biggs PM, de The G, Payne LN (eds) Oncogenesis and Herpesvirus. International Agency for Research on Cancer, Lyons, pp 321–325

    Google Scholar 

  • Heilmeyer L, Begemann H (1961) Blut und Blutkrankheiten. In: Heilmeyer L (Hrsg) Lehrbuch der inneren Medizin, 2. Aufl. Springer, Berlin Göttingen Heidelberg, S 376–449

    Google Scholar 

  • Hellman S, Mauch P, Goodman RL, Rosenthal DS, Molloney W (1978) The place of the radiation therapy in the treatment of Hodgkin’s disease. Cancer 42: 971–978

    PubMed  CAS  Google Scholar 

  • Hellstrom I, Hellstrom KE, Sjogren HD, Warner GA (1971) Demonstration of cell mediated immunity to human neoplasm of various histological types. Int J Cancer 7:1–6

    PubMed  CAS  Google Scholar 

  • Henle W, Henle G (1973) Evidence for an oncogenic potential of the Epstein-Barr virus. Cancer Res 33: 1419–1423

    PubMed  CAS  Google Scholar 

  • Hodgkin T (1832) On some morbid appearances of the absorbent gland and spleen. Med-Chir Trans 17: 68–114

    PubMed  CAS  Google Scholar 

  • Hoeffken K, Schmidt CG (1976) Laparoskopie bei Morbus Hodgkin. Dtsch Med Wschr 101: 814–818

    Google Scholar 

  • Hohl K (1974) Present results in the treatment of malignant lymphomas. Results obtained in a series of 317 cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 233–239

    Google Scholar 

  • Jackson H, Parker F (1944) Hodgkin’s disease. I. General considerations. New Engl J Med 230: 1–8

    Google Scholar 

  • Jackson H Jr, Parker F Jr (1947) Hodgkin’s disease and allied disorders. Oxford Univ Press, New York

    Google Scholar 

  • Jeliff AM, Thomson AD (1955) The prognosis in Hodgkin’s disease. Brit J Cancer 9: 21–36

    Google Scholar 

  • Johnson RE (1973) Total nodal irradiation. J Amer Med Ass 223: 59–61

    CAS  Google Scholar 

  • Johnson RE (1975a) Total body irradiation (TBI) as primary therapy for advanced lymphosarcoma. Cancer (Philadelphia) 35: 242–246

    CAS  Google Scholar 

  • Johnson RE (1975b) Management of generalized malignant lymphoma with “systemic” radiotherapy, Brit J Cancer 31, Suppl II: 450–455

    Google Scholar 

  • Johnson RE, Rühl U (1976) Treatment of chronic lymphocytic leukemia with emphasis on total body irradiation. Int J Radiat Oncol Biol Phys 1: 387–397

    PubMed  CAS  Google Scholar 

  • Johnson RE, De Vita VT, Kun LE, Chabner BR, Chretin PB, Berard CW, Johnson SK (1975) Patterns of involvement with malignant lymphoma and implications for treatment decision making. Brit J Cancer 31, Suppl II: 237–241

    Google Scholar 

  • Johnson RE, Glover MK, Marshall SK (1971) Results of radiation therapy and implications for the clinical staging of Hodgkin’s disease. Cancer Res 31:1834–1837

    PubMed  CAS  Google Scholar 

  • Johnson RE, Thomas LB, Schneider M, Glenn DW, Faw F, Hafermann MD (1970) Preliminary experience with total nodal irradiation in Hodgkin’s disease. Radiology 96: 603–608

    PubMed  CAS  Google Scholar 

  • Johnson RE, Rühl U, Brereton H (1975b) Radiation therapy of malignant lymphomas: Rationale techniques, results. Proceedings of the XI. International Cancer Congress, Florence 1974. Excerpta Medica International Congress Series 354: 374–379

    Google Scholar 

  • Johnson RE, Rühl U. Johnson SK, Glover M (1976) Split-course radiotherapy of Hodgkin’s disease. Cancer 37: 1713–1717

    PubMed  CAS  Google Scholar 

  • Jones SE, Kaplan HS, Rosenberg SA (1972a) Non-Hodgkin’s lymphomas. III. Preliminary results of radiotherapy and a proposal for new clinical trials. Radiology 103: 657 – 662

    PubMed  CAS  Google Scholar 

  • Jones SE, Rosenberg SA, Kaplan HS (1972b) Non-Hodgkin’s lymphomas. I. Bone marrow involvement. Cancer (Philadelphia) 29: 954–960

    CAS  Google Scholar 

  • Jones SE, Rosenberg SA, Kaplan HS, Kadin ME, Dorfman RF (1972c) Non-Hodkin’s lymphomas. II. Single agent chemotherapy. Cancer (Philadelphia) 30: 31–38

    CAS  Google Scholar 

  • Jones SE, Fuchs Z, Bull M, Kadin ME, Dorfman RF, Kaplan HS, Rosenberg SA, Kim H (1973) Non-Hodkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer (Philadelphia) 31: 806–825

    CAS  Google Scholar 

  • Jones SE, Godden J (eds) (1977) Proceecdings of the Conference on Non-Hodgkin’s Lymphomas. September 30 to October 2, 1976, San Francisco, California. Cancer Treat Rep 61: 935–1227

    Google Scholar 

  • Kaplan HS (1962) The radical radiotherapy of regionally localized Hodgkin’s disease. Radiology 78: 533–561

    Google Scholar 

  • Kaplan HS (1966) Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin’s disease. Cancer Res 26: 1221–1224

    PubMed  CAS  Google Scholar 

  • Kaplan HS (1968) Prognostic significance of the relapse free Intervall after radiotherapy in Hodgkin’s disease. Cancer (Philadelphia) 22: 1131–1136

    CAS  Google Scholar 

  • Kaplan HS (1968–1969) On the natural history, treatment and prognosis of Hodgkin’s disease. The Harvey Lectures, Series 64: 215–259. Academic Press, New York, 1970

    Google Scholar 

  • Kaplan HS (1972) Hodgkin’s disease. Harvard Univ. Press, Cambridge/Massachusetts

    Google Scholar 

  • Kaplan HS (1973) Radiotherapy of advanced Hodgkin’s disease with curative intent. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 50–52

    Google Scholar 

  • Kaplan HS (1978) In: Harvey AG, Kagan AR (eds) Modern radiation oncology: Hodgkin’s lymphomas commentary. Harper & Row, Haberstown New York San Francisco London, pp 418–427

    Google Scholar 

  • Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1973) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutive unselected patients. Nat Cancer Inst Monogr 36: 291–301

    PubMed  CAS  Google Scholar 

  • Kaplan HS, Dorfman RF, Nelsen TS, Rosenberg SA (1974) Staging laparotomy and splenectomy in Hodgkin’s disease. Analysis of indications and patterns of involvement in 285 consecutiveunselected cases. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 118–122

    Google Scholar 

  • Keller AR, Kaplan HS, Lukes RJ, Rappaport H (1968) Correlation of histopathology with other prognostic indicators in Hodgkin’s disease. Cancer (Philadelphia) 22: 487–499

    CAS  Google Scholar 

  • Klaue P, Gunzer U, Nürnberger R (1974) Operationsrisiko und diagnostischer Wert der explorativen Laparotomie und Splenektomie bei Morbus Hodgkin. Chirurg 45: 421–425

    PubMed  CAS  Google Scholar 

  • Kleihauer Ü (1978) Hämatologie — Physiologie — Pathologie -Klinik. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Klein G, Clifford G, Henle G, et al (1969) EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int J Cancer 4: 416–421

    PubMed  CAS  Google Scholar 

  • Koppenfels R v (1971) Klinische Erfahrungen im Plasmozytom unter besonderer Berücksichtigung der Röntgendiagnostik und der Strahlentherapie. Strahlentherapie 142: 276–285

    Google Scholar 

  • Kubik S (1974) The anatomy of the lymphatic system. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidleberg New York, pp 233–239

    Google Scholar 

  • Landberg T (1974) Radiosensitivity problems in mantle treatment of Hodkin’s disease, In: Lopez GJ, Monmati J, Berry RH, Hopewell JW (eds) Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Radiology 2: 115–116. Excerpta Medica, Amsterdam

    Google Scholar 

  • Landberg T, Forslo H (1970) Radiosensitivity of mediastinal lymphomas in Hodgkin’s disease treated with split-course radiotherapy. Acta Radiol Ther Phys Biol 9: 177–189

    PubMed  CAS  Google Scholar 

  • Landberg T, Larsson LE (1969) Hodgkin’s disease. Retrospective clinico-pathologic study in 149 patients. Acta Radiol (Stockholm) 8: 390–414

    CAS  Google Scholar 

  • Landberg T, Garwicz S, Ackerman M (1975) A clinico-pathological study of Non-Hodg-kin’s lymphomata in childhood. Brit J Cancer 31, Suppl II: 332–336

    Google Scholar 

  • Lattuada A, Bonadonna G, Milani F, Banfi A, Valagussa P, De Lena M, Monfardini S (1977) Adjuvant chemotherapy with CVP after radiotherapy (RT) in stage I-II Non-Hodkin’s lymphomas. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, Amsterdam

    Google Scholar 

  • Leibfried H, Kerssenfischer V, Fiss N, Werner S (1975) Prognost. Untersuchung. Medizin Technik, Basel

    Google Scholar 

  • Lennert K (1953) Histologische Studien zur Lymphogranulomatose. I. Die Cytologie der Lymphogranulomzellen. Frankfurt Z Path 64: 209–234

    Google Scholar 

  • Lennert K (1967) Classification of malignant lymphomas (European Concept). In: Rüttimann A (ed) Progress in lymphology. Thieme, Stuttgart, pp 103–109

    Google Scholar 

  • Lennert K (1969) Pathologisch-anatomische Klassifikation der malignen Lymphome. In: Becker J, Gauwerky F (Hrsg) Maligne Lymphome. Urban & Schwarzenberg, München Berlin Wien

    Google Scholar 

  • Lennert K (1973a) Pathologisch-histologische Klassifizierung der malignen Lymphome, Pathophysiologie, Klinik, Chemo- und Immuntherapie. Stacher A (Hrsg). Urban & Schwarzenberg, München Berlin Wien, S 181–1994

    Google Scholar 

  • Lennert K (1973b) Follicular lymphoma. A tumor of the germinal centers. In: Akazaki K, Rappaport H, Berard CW, Bennett JM, Ishikawa E (eds) Malignant diseases of the hematopoietic system. GANN Monograph on Cancer Research, vol 15. University of Tokyo Press, Tokyo, pp 217–231

    Google Scholar 

  • Lennert K (1976) Klassifikation und Morphologie der Non-Hodgkin-Lymphome. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien. Hämatologie und Bluttransfusion, Bd. 18. Lehmann, München, S 145–150

    Google Scholar 

  • Lennert K, Stein H, Kaiserling E (1975) Cytological and functional criteria for the classification of malignant lymphoma. Brit J Cancer 31, Suppl II: 29–43

    Google Scholar 

  • Lennert K, in collaboration with Mohri N, Stein H, Kaiserling E, Müller-Hermelink HK (1978) Malignant lymphomas other than Hodgkin’s disease. In: Handbuch der speziellen pathologischen Anatomie und Histologie, Bd I/3B. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Levi JA, Wiernik PH (1977) The therapeutic implications of splenic involvement in stage III A Hodgkin’s disease. Cancer 39: 2158–2165

    PubMed  CAS  Google Scholar 

  • Lewitt SH, Bloomfield CD, Lee CKK, Nesbit ME, McKenna RW (1976) Extended field radiotherapy in Non-Hodgkin’s lymphoma. Radiology 118: 457–459

    Google Scholar 

  • Li JG (1963) The leukocytopenic effect of focal splenic X-irradiation in leukemic patients. Radiology 80: 471–476

    PubMed  CAS  Google Scholar 

  • Lichtenstein L (1953) Histiocytosis X: integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Hand-Schüller-Christian disease. As related manifestations of single nosologic entity. AMA Arch Path 56: 84–102

    CAS  Google Scholar 

  • Lichtenstein L, Jaffe HL (1940) Eosinophilic granuloma of bone. Amer J Path 16: 595–604

    PubMed  CAS  Google Scholar 

  • Lokich JJ, Frei III E, Jaffe N, Tullis J (1976) New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin’s disease. Cancer 38: 667–671

    PubMed  CAS  Google Scholar 

  • Lourdes Z, Nisce G, D’Angio J, Kim JH (1973) Weekly total-skin electron-beam irradiation for mycosis fungoid es. Radiology 109: 638–686

    Google Scholar 

  • Lowenbraun S, Sutherland IC, Feldman MJ, Serpick AA (1971) Transformation of reticulum cell sarcoma to acute leukemia. Cancer (Philadelphia) 27: 579–585

    CAS  Google Scholar 

  • Lukes RJ (1963) Relationship of histologic features to clinical stages in Hodgkin’s disease. Amer J Roentgenol 90: 944–955

    PubMed  CAS  Google Scholar 

  • Lukes RJ (1968) The pathologic picture of the malignant lymphomas. In: Zarafonatis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 333–356

    Google Scholar 

  • Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin’s disease. Cancer Res 26: 1063–1081

    PubMed  CAS  Google Scholar 

  • Lukes RJ, Butler JJ, Hicks EB (1966a) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer (Philadelphia) 19: 317–344

    Google Scholar 

  • Lukes RJ, Collins RD (1974) Functional approach to the classification of malignant lymphoma. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 19–30

    Google Scholar 

  • Lukes RJ, Collins RD (1975) New approaches to the classification of the lymphomata. Brit J Cancer 31: 1–28

    Google Scholar 

  • Lukes RJ, Craver LF, Hall TC, Rappaport H, Rubin P (1966b) Report of the nomenclature comittee. Cancer Res 26: 1311

    Google Scholar 

  • MacMahon B (1957) Epidemiological evidence on the nature of Hodgkin’s disease. Cancer (Philadlephia) 10: 1045–1054

    CAS  Google Scholar 

  • McKelvey EM, Moon TE (1977) Curability of Non-Hodgkin’s lymphomas. Cancer Treat Rep 61: 1185–1190

    PubMed  CAS  Google Scholar 

  • Meuret G, Hoffmann G, Gmelin R (1975) Erfahrungen mit der Radiophosphor-Therapie bei Polycythaemia vera. Strahlentherapie 149: 49–54

    PubMed  CAS  Google Scholar 

  • Meuret G, Fliedner TM, Schütz W, Öhl N, Afkham J, Obrecht P, Musshoff K (1971) Erfahrungen mit der extrakorporalen Blutbestrahlung bei der Behandlung der chronisch-lymphatischen Leukämie. Klin Wochenschr 49: 899–904

    PubMed  CAS  Google Scholar 

  • Meuret G, Schütz W, Harris EB, Fliedner TM, Hoelzer D, Afkham J, Obrecht P, Musshoff K, Heinze V. Tourkantonis A (1969) Die Behandlung der chronisch-lymphatischen Leukämie durch extrakorporale Blutbestrahlung unter Verwendung konventioneller Strahlentherapiegeräte. Strahlentherapie 137: 429–441

    PubMed  CAS  Google Scholar 

  • Meusers R, Bartels H, Brittinger G, Common H, Dühmke E, Fülle HH, Gunzer U, Heinz R, König E, Musshoff K, Pralle H, Schmalhorst U, Theml H, Krüger GRF, Lennert K (1979) Heterogenity of diffuse histiocytic lymphoma as demonstrated by the Kiel Classification. N Engl J Med: 384

    Google Scholar 

  • Mill WB (1975) Radiation therapy in multiple myeloma. Radiology 115: 175–178

    PubMed  CAS  Google Scholar 

  • Moore MR, Bull JM, Jones SE, Rosenberg SA, Kaplan HS (1977) Sequential radiotherapy and chemotherapy in the treatment of Hodgkin’s disease: a progress report. Ann Intern Med 77: 1–9

    Google Scholar 

  • Moss WT, Brand WN, Battifora H (1973) Radiation oncology. Rationale, technique results, 4th ed. Mosby, St. Louis

    Google Scholar 

  • Murphy SB (1976) Non-Hodgkin’s lymphomas of childhood. In: Donaldson M, Sendel HG (eds) Trends in childhood cancer. Wiley, New York, p 31

    Google Scholar 

  • Murphy SB (1977) Management of childhood Non-Hodkin’s lymphoma. Cancer Treat Rep 61: 1161–1173

    PubMed  CAS  Google Scholar 

  • Musshoff K (1967) Systematische prophylaktische Bestrahlung bei Systemerkrankungen (Morbus Hodgkin). Strahlentherapie Sonderbd 64, Teil B: 74–86

    Google Scholar 

  • Musshoff K (1968) Die Strahlentherapie der Leukosen. Internist 9: 484–489

    PubMed  CAS  Google Scholar 

  • Musshoff K (1971) Prognostic and therapeutic implications of staging in extranodal Hodgkin’s disease. Cancer Res 31: 1814–1827

    PubMed  CAS  Google Scholar 

  • Musshoff K (1972) Grundlagen der Strahlentherapie des Morbus Hodgkin. Indikation und Ergebnisse. Z Krebsforsch 78: 162–191

    CAS  Google Scholar 

  • Musshoff K (1973) Survival and relapse data in Hodgkin’s disease. Freiburg im Breisgau 1948–1969. Int Symp Hodgkin’s disease, Stanford University School of Medicine, Stanford, Calif., March 20–24, 1972. Nat Cancer Inst Monogr 36: 531–539

    PubMed  CAS  Google Scholar 

  • Musshoff K (1978) Voraussetzungen und Probleme der adjuvanten Chemotherapie in Verbindung mit der primären Strahlentherapie der Nicht-Hodgkin-Lymphome unter besonderer Berücksichtigung der Histologie. Hämatologie Bluttransfusion 22: 101–114

    CAS  Google Scholar 

  • Musshoff K (1979) Die Strahlentherapie der Non-Hodgkin-Lymphome. Indikation und Probleme. In: Stacher A, Höcker P (Hrsg) Lymphknotentumoren. Urban & Schwar-zenberg, München Wien Baltimore, S 157–165

    Google Scholar 

  • Musshoff K, Boutis L (1967) Die Frage der Heilbarkeit der Lymphogranulomatose, beurteilt nach den Behandlungsergebnissen der Freiburger Medzinischen Klinik. Verh Dtsch Ges Inn Med 73: 322–329

    PubMed  CAS  Google Scholar 

  • Musshoff K, Boutis L (1968) Therapy results in Hodgkin’s disease. Freiburg i.Br., 1948–1966. Cancer 21: 1100–1113

    PubMed  CAS  Google Scholar 

  • Musshoff K, Leopold H (1978) On the question of the tumoricidal dose in Non-Hodgkin’s lymphomas. In: Mathé G, Seligmann M, Tubiana M (eds) Recent results in cancer research, vol 65. Springer, Berlin Heidelberg New York, S. 203–206

    Google Scholar 

  • Musshoff K, Schmidt-Vollmer H (1975a) Prognostic significance of primary site after radiotherapy in Non-Hodkin’s lymphomata. Brit J Cancer 31, Suppl II: 425–434

    Google Scholar 

  • Musshoff K, Schmidt-Vollmer H (1975b) Prognosis of Non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83: 323–341

    CAS  Google Scholar 

  • Musshoff K, Slanina J (1974a) Die Strahlenbehandlung der Lymphogranulomatose. Internist 15: 85–92

    PubMed  CAS  Google Scholar 

  • Musshoff K, Slanina J (1974b) Stadieneinteilung der malignen Lymphome — zugleich ein Beitrag über die Bedeutung der Laparatomie mit Splenektomie. Klin Wochenschr 52: 109–117

    PubMed  CAS  Google Scholar 

  • Musshoff K, Stamm H, Lümmel G, Gössel K (1964) Zur Prognose der Lymphogranulomatose. Klinisches Bild und Strahlentherapie. Freiburger Krankengut 1938–1958. Beiträge zur inneren Medizin. Schattauer, Stuttgart, S. 549–561

    Google Scholar 

  • Musshoff K, Boutis L, Obrecht P, Karsch T (1968a) Die Lebenserwartung bei der chronischen myeloischen Leukaemie in Abhängigkeit von der Therapie. Freiburger Ergebnisse 1945–1966. Verh Dtsch Ges Inn Med 74: 648–652

    PubMed  CAS  Google Scholar 

  • Musshoff K, Renemann H, Boutis L, Afkham J (1968b) Die extranoduläre Lymphogranulomatose: Diagnose, Therapie und Prognose bei zwei unterschiedlichen Formen des Organbefalls. Ein Beitrag zur Stadieneinteilung des Morbus Hodgkin. Fort sehr Röntgenstr 104: 776–786

    Google Scholar 

  • Musshoff K, Boutis L, Obrecht P, Karsch T (1969) Die Lebenserwartung der chronischen myeloischen Leukaemie in Abhängigkeit von individuellen und krankheitsspezifischen Faktoren und der Therapie. Freiburger Ergebnisse 1947–66. Klin Wschr 47: 179–183

    PubMed  CAS  Google Scholar 

  • Musshoff K, Oehlert W, Hamann W, Nuss A (1970a) Radiation therapy and cure in Hodgkin’s disease. Acta Radiol Ther Phys Biol 9: 289–301

    PubMed  CAS  Google Scholar 

  • Musshoff K, Renemann H, Boutis L, Afkham J (1970b) The differentiation of two different types of stage IV of Hodgkin’s disease. II. International Congress of Lymphol-ogy, Miami, March 15–20, 1968. Progress in Lymphology II. Thieme, Stuttgart, pp 272–275

    Google Scholar 

  • Musshoff K, Schmidt-Vollmer H, Merten D (1971) Reticulum cell sarcoma: An onocological model for a system of classifying the malignant lymphoma. Europ J Cancer 7: 451–457

    CAS  Google Scholar 

  • Musshoff K, Hartmann C, Niklaus B, Rossner R (1974a) Results of therapy in Hodgkin’s disease. Freiburg i. Br. 1964–1971. In: Musshoff K (ed) Recent results in cancer research, vol 46. Springer, Berlin Heidelberg New York, pp 206–220

    Google Scholar 

  • Musshoff K, Hartmann CHG, Niklaus B, Rossner R (1974b) Prognostic value of the survival, remission, and recurrence rates of Hodgkin’s disease following radiation therapy. In: Lopez GH, Bonmati J, Berry RH, Hopewell JW (eds) Radiology. Proceedings of the XIII. International Congress of Radiology, Madrid, October 15–20, 1973. Excerpta Medica, Amsterdam; American Elsevier, New York, pp 7–10

    Google Scholar 

  • Musshoff K, Staib J, Oehlert W, Pauli-Beisel C, Löhr G-W, Slanina J, Böttcher D (1974c) Primäre und sekundäre Laparotomie mit Splenektomie bei Patienten mit Morbus Hodgkin. Vorläufige Ergebnisse im Freiburger Krankengut. Klin Wochenschr 52: 24–29

    PubMed  CAS  Google Scholar 

  • Musshoff K, Hartmann C, Niklaus B, Rossner R (1976) The prognostic significance of first and second remission in Hodgkin’s disease after first and second relapse radiotherapy. Z Krebsforsch 85: 243–270

    CAS  Google Scholar 

  • Musshoff K, Schmidt-Vollmer H, Lennert K, Sandritter W (1976) Preliminary clinical findings on the Kiel Classification of malignant lymphomas. Z Krebsforsch 87: 229–238

    CAS  Google Scholar 

  • Musshoff K, Stotzingen W von, Schmidt-Vollmer H (eingereicht) Investigation results of a comparison between the Rappaport and the Kiel Classification of the non-Hodgkin lymphomas, together with clinical data. J Cancer Res Clin Oncol

    Google Scholar 

  • Neidhart B, Hartwich G, Schwemmle K, Hermanek P, Seiler G (1975) Explorative Lapa-ratomie und Splenektomie bei Lymphogranulomatose. Dtsch Med Wochenschr 100: 1487–1492

    Google Scholar 

  • Ochsner SF (1966) Eosinophile granuloma of bone. Experience with 20 cases. Amer J Roentgenol 97: 719–726

    PubMed  CAS  Google Scholar 

  • O’Connell MJ, Wiernik PH, Brace KC, Byhardt RW, Green WH (1975) A combined modality approach to the treatment of Hodgkin’s disease; preliminary results of a prospectively randomized clinical trial. Cancer 35: 1055–1064

    PubMed  Google Scholar 

  • Olmer J, Gabriel B, Bove J (1967) Zur Behandlung der chronischen myeloischen Leu-kaemie. Dtsch Röntgenkongreß 1966, Teil B, S 276–277

    Google Scholar 

  • Ottani S, Ehrlich JC (1940) Solitary granuloma of bone simulating primary neoplasm. Amer J Pathol 16: 479–490

    Google Scholar 

  • Page V, Gardner A, Karzmark CJ (1970a) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. The mantle technique. Radiology 96: 609–618

    PubMed  CAS  Google Scholar 

  • Page V, Gardner A, Karzmark C (1970b) Physical and dosimetric aspects of the radiotherapy of malignant lymphomas. II. The inverted Y-technique. Radiology 96: 619 – 626

    PubMed  CAS  Google Scholar 

  • Peckham MJ (ed) (1975) Non-Hodgkin’s lymphomata, Symposium held at the Royal Institution, London, October 1973. Brit J Cancer 31, Suppl II

    Google Scholar 

  • Peters MV (1950) A study of survivals in Hodgkin’s disease treated radiologically. Amer J Roentgenol 63: 299–311

    Google Scholar 

  • Peters MV (1961) The place of irradiation in the control of Hodgkin’s disease. In: Proceedings of the IV. National Cancer Conference 1960. Lippincott, Philadelphia, pp 571–584

    Google Scholar 

  • Peters MV (1966) Prophylactic treatment of adjacent areas in Hodgkin’s disease. Cancer Res 26: 1232–1243

    PubMed  CAS  Google Scholar 

  • Peters MV, Brown TC, Rideout DF (1973) Prognostic influences and radiation therapy according to pattern of disease. In: Rubin P (ed) Updated Hodgkin’s disease: B. Curability of localized disease. J Amer Med Ass 223: 53–58

    Google Scholar 

  • Peters MV, Hasselback R, Brown TC (1968) The natural history of the lymphomas related to the clinical classification. In: Zararonetis CJD (ed) Proceedings of the International Conference on Leukemia-Lymphoma. Lea & Febiger, Philadelphia, pp 357–370

    Google Scholar 

  • Peters MV, Bush RS, Brown TC, Reid J (1975) The place of radiotherapy in the control of non-Hodgkin’s lymphomata. Brit J Cancer 31, Suppl II: 386–401

    Google Scholar 

  • Peters MV, Middlemiss KCH (1958) Study of Hodgkin’s disease treated by irradiation. Amer J Roentgenol 79: 114–121

    PubMed  CAS  Google Scholar 

  • Pfeiffer J (1965) Zur Diagnostik und Therapie des eosinophilen Knochengranuloms. Strahlentherapie 126: 42–52

    PubMed  CAS  Google Scholar 

  • Pinkel D, Somone J, Hustu HO, Aur RJA (1972) Nine years experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics 50: 246–251

    PubMed  CAS  Google Scholar 

  • Pinkel D, Johnson W, Aur RJA (1975) Non-Hodgkin’s lymphoma in children. Brit J Cancer 31, Suppl II: 298–323

    Google Scholar 

  • Portlock CS, Rosenberg SA, Glatstein E, Levy R, Kaplan HS (1977) Failure of initial therapy for stage I, II and III Hodgkin’s disease: salvage management (Abstr). Proc Amer Soc Clin Oncol 18: 342

    Google Scholar 

  • Porzig KJ, Portlock CS, Robertson A, Rosenberg SA (1978) Treatment of advanced Hodgkin’s disease with B-CAVe following MOPP failure. Cancer 41: 1670–1675

    PubMed  CAS  Google Scholar 

  • Prager PJ, Menges V, DiBiase M, Wurster KH, Krastel A, Assmus H (1976) Das eosinophile Knochengranulom beim Erwachsenen. Radiologe 16: 21–28

    PubMed  CAS  Google Scholar 

  • Prosnitz LR, Rafael L, Montalvol BA, Fischer DB, Silberstein AB, Berger DS (1978) Treatment of stage III A Hodgkin’s disease: Is radiotherapy alone adequate? Int J Radiat Oncol Biol Phys 4: 781 – 787

    PubMed  CAS  Google Scholar 

  • Rai KR, Sawithky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46: 219–234

    PubMed  CAS  Google Scholar 

  • Rajewski B (1954) Strahlendosis und Strahlenanwendung. Thieme, Stuttgart

    Google Scholar 

  • Rappaport H (1966) Tumors of the hematopoetic system. Armed Forces Institute of Pathology, Sect 3, fase 8. Washington DC, pp 91–156

    Google Scholar 

  • Pappaport H, Strum SB (1970) Vascular invasion in Hodgkin’s disease: Its incidence and relationship to the spread of the disease. Cancer (Philadlephia) 25: 1304–1313

    Google Scholar 

  • Rappaport H, Winter WJ, Hicks EB (1956) Follicular lymphoma: A reevaluation of its position in the scheme of malignant lymphomas, based on a survey of 253 cases. Cancer (Philadelphia) 9: 729–821

    Google Scholar 

  • Ratkóczy N (1936) Herdvernichtungsdosen in der Röntgentherapie der Lymphogranulomatose. Strahlentherapie 56: 325–336

    Google Scholar 

  • Renner H (1973) Strahlentherapeutische Aspekte des multiplen Myeloms. Strahlentherapie 146: 15–23

    PubMed  CAS  Google Scholar 

  • Revol L, Cordat M, Rouhier D, Clavel M, Jeune R, Guyon JM, Chassard JL, Papillon J (1974) Quelques considération sur la radiothérapie dans la leucémie myéloide chronique. Strahlentherapie 148: 572–578

    PubMed  CAS  Google Scholar 

  • Riehm H, Gadner H, Weite K (1977) Die West-Berliner Studie zur Behandlung der akuten lymphoblastischen Leukämie des Kindes — Erfahrungsbericht nach 6 Jahren. Klin Pädiat 189: 89–102

    CAS  Google Scholar 

  • Robb-Smith AHT (1947) The lymph node biopsy. In: Recent advances in clinical pathology. Churchill, London, pp 350–370

    Google Scholar 

  • Rosenberg SA (1961) Lymphosarcoma: A review of 1269 cases. Medicine (Baltimore) 40: 31–84

    CAS  Google Scholar 

  • Rosenberg SA (1966) Report of the Staging Committee of Hodgkin’s disease. Cancer Res 26: 1310

    Google Scholar 

  • Rosenberg SA, Kaplan HS (1966) Evidence for an orderly progression in the spread of Hodgkin’s disease. Cancer Res 26: 1225–1230

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Kaplan HS (1970) Hodgkin’s disease and other malignant lymphomas. Calif Med 113: 23–38

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Kaplan HS (1975a) The management of stage I, II and HI Hodgkin’s disease with combined radiotherapy and chemotherapy. Cancer (Philadelphia) 35: 55–63

    CAS  Google Scholar 

  • Rosenberg SA, Kaplan HS (1975b) Clinical trials in the non-Hodkin’s lymphomata at Stanford University experimental design and preliminary results. Brit J Cancer 31, Suppl II: 456–464

    Google Scholar 

  • Rosenberg SA, Boiron M, DeVita VT, Johnson RE, Lee BJ, Ullmann JE, Viamonte M (1971) Report of the Committee on Hodgkin’s disease staging procedures. Cancer Res 31: 1862–1863

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Kaplan HS, Glatstein E, Portlock SC (1977) The role of adjuvant MOPP in the radiation therapy of Hodgkin’s disease: a progress report after eight years on the Stanford trials. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer. Elsevier/North Holland, Amsterdam, pp 505–515

    Google Scholar 

  • Rosenberg SA, Kaplan HS, Glatstein EJ, Portlock CS (1978) Combined modality therapy of Hodgkin’s disease — Report of the Stanford trials. Cancer 42: 991–1000

    PubMed  CAS  Google Scholar 

  • Rosenthal SR (1936) Significance of tissue lymphocytes in the prognosis of Lymphogranulomatose. Arch Path 21: 628–646

    Google Scholar 

  • Rous P (1911) Transmission of a malignant new growth by means of cell-free filtrate. J Amer Med Ass 56: 198–201

    Google Scholar 

  • Rühl U (1977) Ganzkörperbestrahlung bei Non-Hodgkin-Lymphomen als Alternative zur Chemotherapie. Strahlentherapie 153: 299–303

    PubMed  Google Scholar 

  • Rühl U, Johnson RE (1975) Ganzkörperbestrahlung in der Behandlung der chronischen Lymphadenose. Vortrag; Deutsch-Österr. Hämatologen-Kongreß, Bad Nauheim

    Google Scholar 

  • Salzmann JR, Kaplan HS (1971) Effect of splenectomy on hematologic tolerance during total lymphoid radiotherapy of patients with Hodgkin’s disease. Cancer 27: 471–478

    Google Scholar 

  • Schein PS, Chabner BA, Canellos GP, Young RC, DeVita VT Jr (1975) Non-Hodgkin’s lymphoma: Patterns of relapse from complete remission after combination chemotherapy. Cancer 35: 354–357

    PubMed  CAS  Google Scholar 

  • Schmidt-Vollmer H, Musshoff K, Lennert K, Sandritter W, Stiefelhaben H (1975) Vorläufige Befunde zur Prognose der Kiel-Klassifikation der malignen Non-Hodgkin-Lymphome. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9–1.10.1975

    Google Scholar 

  • Schmitz H, Scherer H (1972) IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Ges Virusforsch 37: 332–339

    PubMed  CAS  Google Scholar 

  • Schoen D, Bauer R (1968) Ergebnisse der Milzbestrahlung bei 175 Fällen mit chronisch-myeloischer Leukämie. Strahlentherapie 135: 1–10

    PubMed  CAS  Google Scholar 

  • Scott RB (1957) Leukaemia: chronic lymphatic leukaemia. Lancet 1957 I: 1162–1167

    Google Scholar 

  • Sherins RJ, DeVita VT Jr (1973) Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy. Ann Intern Med 79: 216–220

    PubMed  CAS  Google Scholar 

  • Slanina J, Musshoff K, Rahner T, Stiassny R, in cooperation with: Barmeyer J, Baumeister L, Berger W, Dichgans J, Gehring G, Grub R, Heite H-J, Hennekeuser HH, Herkel L, Krüssmann K, Kuphal K, Löhr G-W, Möbius W, Rossner R, Schmidt-Vollmer H (1977) Long-term side effects in irradiated patients with Hodgkin’s disease. Int J Radiat Oncol Biol Phvs 2: 1–19

    CAS  Google Scholar 

  • Slanina J, Kuphal K, Riegsinger A (1980) Anwendung des Split-Course-Verfahrens bei der total nodalen Systembestrahlung der Hodgkin’schen Erkrankung. Strahlentherapie 156: 18–25

    PubMed  CAS  Google Scholar 

  • Smetana HF, Cohen BM (1956) Mortality in relation to histologic type in Hodgkin’s disease. Blood 11: 211 – 224

    PubMed  CAS  Google Scholar 

  • Speck B (1975) Möglichkeiten und Probleme der klinischen Knochenmarkstransplantation. Med Welt (Berlin) 26: 39–43

    CAS  Google Scholar 

  • Spiegelman S, Axel R, Baxt W, Jufe D, Schlom J (1974) Human cancer and animal viral oncology. Cancer (Philadelphia) 34: 1406–1420

    CAS  Google Scholar 

  • Stacher A, Theml H, Waldner R (1975) Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kieler Klassifikation: Immunocytom und chronische lymphatische Leukämie. Gemeinsame Tagung der Deutschen und Österreichischen Gesellschaft für Hämatologie, Bad Nauheim, 29.9.–1.10.1975

    Google Scholar 

  • Stein H (1976) Klassifikation der malignen Non-Hodgkin-Lymphome aufgrund gemeinsamer morphologischer und immunologischer Merkmale zwischen normalen und neoplastischen Zellen. Immun Infekt 4: 52–69 und 95–109

    PubMed  CAS  Google Scholar 

  • Stein RS, Hilborn RM, Flexner JM, Bolin M, Stroup S, Reynolds V, Krantz S (1978) Anatomical sub stages of stage III Hodgkin’s disease. Implications for staging, therapy and experimental design. Cancer 42: 429–436

    PubMed  CAS  Google Scholar 

  • Stenfert-Kroese WF, Cleton FJ, Somers R (1974) Leukaemic progression in lympho-mata. Symposium on Non-Hodgkin’s lymphomata. London, October 8–10 1973. Brit J Cancer 30, Suppl II: 102–106

    Google Scholar 

  • Strauchen JA, Young RC, DeVita VT Jr, Anderson T, Fantone YC, Berard CW (1978) Clinical relevance of the histopathological sub classificai ion of diffuse “histocytic” lymphome. New Engl J Med 299: 1382–1387

    PubMed  CAS  Google Scholar 

  • Strickstrock KH, Musshoff K, Boutis L (1967) Methode der zusätzlichen prophylaktischen Bestrahlung bei der Lymphogranulomatose. Strahlentherapie 133: 337–348

    PubMed  CAS  Google Scholar 

  • Symposium International organisé à Paris de 15 Février 1965 sous la direction de M. Maurice Tubiana: La radiothérapie de la maladie de Hodgkin. J Radiologie, Suppl 47: 1–176

    Google Scholar 

  • Symposium (1971) Staging in Hodgkin’s disease. Ann Arbor/Michigan, April 26–28, 1971. Cancer Res 31: 1707–1870

    Google Scholar 

  • Symposium International on Hodgkin’s disease (1973) Stanford (Calif), March 20–24, 1972. Natl Cancer Inst Monogr 36: 1 – 587

    Google Scholar 

  • Symposium on Non-Hodgkin’s lymphomata (1975) London, October 8–12, 1973. Pckham MJ (ed). Brit J Cancer 30, Suppl II: 1–511

    Google Scholar 

  • Teschendorf W (1927) Über Bestrahlung des ganzen menschlichen Körpers bei Blutkrankheiten. Strahlentherapie 26: 720–728

    Google Scholar 

  • Tschendorf W (1953) Die Teleröntgentherapie. Thieme, Stuttgart

    Google Scholar 

  • Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49: 511 – 533

    PubMed  CAS  Google Scholar 

  • Todd IDH (1965) Treatment of solitary plasmacytoma. Klin Radiol 16: 385–399

    Google Scholar 

  • Töppner R (1952) Zur Behandlung des eosinophilen Granulomes mit Röntgenstrahlen. Strahlentherapie 88: 362–376

    PubMed  Google Scholar 

  • Tubiana M, Attie E, Flamant R, Gerard-Marchant R, Hayat M (1971) Prognostic factors in 454 cases of Hodgkin’s disease. Cancer Res 31: 1801–1810

    PubMed  CAS  Google Scholar 

  • Tulinius H (1974) Epidemiology of Hodgkin’s disease. XI. International Cancer Congress, Florence, October 20–26, 1974

    Google Scholar 

  • Veronesi U. Musumeci R, Pizzetti F, Gennari L, Bonadonna G (1974) The value of staging laparotomy in Non-Hodgkin’s lymphomas. Cancer (Philadelphia) 33: 446–459

    CAS  Google Scholar 

  • Vianna NJ, Koegh MD, Polan AK, Greenwald P (1974) Hodgkin’s disease mortality among physicians. Lancet 1974 II: 131–132

    Google Scholar 

  • Wachtler F (1961) Über die Strahlenbehandlung des eosinophilen Knochengranuloms. Krebsarzt 16: 193–197

    PubMed  CAS  Google Scholar 

  • Wannenmacher M, Slanina J, Kuphal K, Bruggmoser G (1978) Gegenwärtiger Stand der Großfeldtechnik unter Megavoltbedinungen bei der Strahlentherapie der Hodgkin’-schen Erkrankung — Grundlagen, Durchführung, Nebenwirkungen. Radiologe 18: 371–387

    PubMed  CAS  Google Scholar 

  • Watanabe A, Sullivan MP, Sutow WW, Wilbur R (1973) Undifferentiated lymphoma of non-Burkitt’s type. Amer J Dis Child 125: 57–61

    PubMed  CAS  Google Scholar 

  • Wehinger H, Slanina J, Jacobi H, Musshoff K, Dietz V, Sauer M, Dilger M (1974) Prophylactic central nervous system therapy with cranial irradiation and intrathecal methotrexate in acute lymphoblastic leukaemia of childhood. Strahlentherapie 148: 590–598

    PubMed  CAS  Google Scholar 

  • Weller S, Glatstein E, Castellino RA, Kaplan HS, Rosenberg SA (1977) Initial relapse in previously treated Hodgkin’s disease. — II. Retrograde transdiaphragmatic extension. Int J Radiat Oncol Biol Phys 2: 863–872

    PubMed  CAS  Google Scholar 

  • Werf-Messing B van der (1968) Reticulum cell sarcoma and lymphosarcoma. A retrospective study of potential survival in loco-regional disease. Europ J Cancer 4: 549 – 557

    Google Scholar 

  • Worthy TS (1975) The place of laparotomy in the cure of Hodgkin’s disease. 3. Kongreß der Europäischen Radiologischen Gesellschaft, Edinburgh, 22.–27. Juni 1975

    Google Scholar 

Download references

Authors
  1. K. Musshoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Slanina
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Radiologisches Zentrum, Strahlen- und Poliklinik, Universitätsklinikum Essen, Hufelandstr. 55, 4300, Essen, Deutschland

    Eberhard Scherer

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Musshoff, K., Slanina, J. (1980). Maligne Systemerkrankungen. In: Scherer, E. (eds) Strahlentherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96542-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-96542-5_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-09780-8

  • Online ISBN: 978-3-642-96542-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation